ZBH/Addendum to #msg-154160133—On the 3/2/20 RJ webcast, management said elective procedures in China were down 80-90% during February, and ZBH expects no improvement in March. In normal times, China comprises 5% of ZBH's sales.
If this webcast had been held today (only 3 days later!), the discussion probably would've focused on the US market rather than China.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”